Radisys Corp. (RSYS) Financials Nov 14, 2014, 4:00

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Radisys Corp. (RSYS) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Radisys Corp.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 304.27M 284.31M 330.87M 286.1M 237.86M
Cost of Goods Sold (COGS) incl. D&A 214.04M 197.83M 236.84M 203.56M 179.44M
COGS excluding D&A 198.69M 185.82M 219.97M 181.48M 157.69M
Depreciation & Amortization Expense 15.35M 12.01M 16.86M 22.08M 21.75M
Depreciation 6.29M 5.1M 5.59M 7.32M 7.97M
Amortization of Intangibles 9.06M 6.91M 11.27M 14.76M 13.77M
Gross Income 90.23M 86.48M 94.03M 82.54M 58.43M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 86.99M 83.48M 97.79M 93.21M 86.91M
Research & Development 41.89M 38.68M 44.95M 47.92M 45.54M
Other SG&A 45.11M 44.8M 52.85M 45.29M 41.37M
Other Operating Expense 0 730,000 0 0 0
Unusual Expense 5.44M 1.58M 7.64M 29.08M 7.48M
EBIT after Unusual Expense (5.44M) (1.58M) (7.64M) (29.08M) (7.48M)
Non Operating Income/Expense 211,000 (154,000) 513,000 545,000 2.71M
Non-Operating Interest Income 1.12M 636,000 99,000 39,000 26,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 2.37M 2.04M 1.87M 1.72M 1.22M
Gross Interest Expense 2.37M 2.04M 1.87M 1.72M 1.22M
Interest Capitalized 0 0 0 0 0
Pretax Income (3.23M) (854,000) (12.66M) (40.88M) (34.45M)
Income Tax 39.34M (485,000) (8.44M) 2.59M 14.96M
Income Tax - Current Domestic 49,000 (332,000) 38,000 122,000 (70,000)
Income Tax - Current Foreign 532,000 (573,000) 548,000 1.25M 2.3M
Income Tax - Deferred Domestic 42M 0 (6.74M) (68,000) 0
Income Tax - Deferred Foreign (3.25M) 420,000 (2.28M) 1.28M 12.73M
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (42.57M) (369,000) (4.23M) (43.47M) (49.4M)
Minority Interest Expense 0 0 0 0 0
Net Income (42.57M) (369,000) (4.23M) (43.47M) (49.4M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (42.57M) (369,000) (4.23M) (43.47M) (49.4M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (42.57M) (369,000) (4.23M) (43.47M) (49.4M)
EPS (Basic) (1.81) (0.02) (0.17) (1.60) (1.72)
Basic Shares Outstanding 23.49M 24.14M 25.41M 27.17M 28.81M
EPS (Diluted) (1.81) (0.02) (0.17) (1.60) (1.72)
Diluted Shares Outstanding 23.49M 24.14M 25.41M 27.17M 28.81M
EBITDA 18.6M 14.29M 13.1M 11.41M (6.74M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading